Vogl, S E <br/><br/>
A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.  [electronic resource] 

 -  Cancer  Aug 1985 
 - 432-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19850801)56:3<432::aid-cncr2820560304>3.0.co;2-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--administration & dosage<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Female<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Prognosis